Diagnostics and Therapeutics for HIV: Global Markets

1
Diagnostics and Therapeutics for HIV Global
Markets
One-Stop Shop for Business Information
2
Summary
The global market for HIV therapeutics and
diagnostics is expected to grow to 18.2 billion
in 2013 and 19.6 in 2018, with a compound annual
growth rate (CAGR) of 1.5. This report
provides -An overview of the global market for
HIV therapeutics and diagnostics-Analyses of
global market trends, with data from 2013, and
estimates and projections of CAGRs through
2018. -Discussion of improvements in advanced
treatments and diagnostic methods. -Examination
of cost implications for treatments accross a
wide range of countries -A look at ongoing
research and the future direction of the market.
3
STUDY GOALS AND OBJECTIVES The aim of this
report is to provide detailed market, technology
and industry analyses to help readers quantify
and qualify the market for products used in the
treatment, testing and prophylaxis of HIV/AIDS.
Important trends are identified and sales
forecasts by product categories and major country
markets are provided through 2018 these are
based on industry sources and considered
assessment of the regulatory environment,
health-care policies, demographics and other
factors that directly affect the HIV/AIDS market.
The wider economic environment is also taken into
account.
4
REASONS FOR DOING THE STUDY HIV/AIDS is one of
the most catastrophic threats to human health
throughout the world. Advanced treatment options
and improved methods of diagnosis have helped to
moderate the growth of the epidemic and this has
presented opportunities for companies prepared to
engage actively in this field. However, the
management of HIV/AIDS is still, in many
respects, an unfulfilled market and there is an
ongoing, urgent need for promising new research
directions as well as optimal exploitation of the
treatment and diagnostic options already
developed. In this dynamic and continually
evolving marketplace, there is a need for an
up-to-date, comprehensive appraisal covering both
strategic and tactical options confronting the
pharmaceutical industry.
5
SCOPE AND FORMAT This report summarizes the
market of HIV/AIDS products and discusses the
present status and evolution of antiretroviral
(ARV) drugs with analyses by selected major
national markets. The latest treatment and
diagnostic options and practices are described
and their cost implications clarified, especially
in the context of treatment affordability in
countries of widely varying economic status. The
emergence of a considerable generic medicine
component in the marketplace, alongside the
presence of original branded medicines, is
discussed. The current market for antiretroviral
therapies is analyzed, with breakdowns by drug
categories, and the leading drugs of 2012 are
discussed. Five-year forecasts are provided with
reasonable explanations.
6
Table Of Content

1. INTRODUCTION
2. SUMMARY
3. OVERVIEW
4. GLOBAL MARKET
5. HIV THERAPEUTICS MARKET LEADING ARV DRUG
   CATEGORIES
6. HIV THERAPEUTICS MARKET LEADING DRUGS
7. ARV DRUGS PIPELINE ANALYSIS
8. HIV TESTING AND DIAGNOSTICS
9. HIV PROPHYLAXIS
10. HIV VACCINES

7
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and benchmarks.

8

• To know more
• Diagnostics and Therapeutics for HIV Global
  Markets

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com